Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1879 1
1911 1
1929 1
1931 2
1933 1
1934 1
1943 1
1945 6
1946 25
1947 36
1948 49
1949 48
1950 125
1951 129
1952 102
1953 107
1954 100
1955 93
1956 101
1957 122
1958 107
1959 115
1960 107
1961 128
1962 130
1963 204
1964 223
1965 262
1966 238
1967 213
1968 249
1969 272
1970 295
1971 264
1972 321
1973 354
1974 373
1975 382
1976 417
1977 469
1978 510
1979 474
1980 520
1981 517
1982 589
1983 609
1984 672
1985 621
1986 669
1987 768
1988 718
1989 782
1990 723
1991 764
1992 786
1993 804
1994 960
1995 1005
1996 1072
1997 1169
1998 1315
1999 1512
2000 1641
2001 1660
2002 1667
2003 1839
2004 2017
2005 2261
2006 2401
2007 2645
2008 2901
2009 3082
2010 3468
2011 3920
2012 4214
2013 4756
2014 5051
2015 5233
2016 5414
2017 5453
2018 5589
2019 5933
2020 4846
2021 4
Text availability
Article attribute
Article type
Publication date

Search Results

91,028 results
Results by year
Filters applied: . Clear all
Page 1
Multiple sclerosis: clinical aspects.
Oh J, Vidal-Jordana A, Montalban X. Oh J, et al. Curr Opin Neurol. 2018 Dec;31(6):752-759. doi: 10.1097/WCO.0000000000000622. Curr Opin Neurol. 2018. PMID: 30300239 Review.
RECENT FINDINGS: Multiple sclerosis is increasing in incidence and prevalence globally, even in traditionally low-prevalence regions of the world. ...SUMMARY: A number of recent advances have been made in the clinical diagnosis and prognostication of multiple
RECENT FINDINGS: Multiple sclerosis is increasing in incidence and prevalence globally, even in traditionally low-prevalence r …
Progressive multiple sclerosis: from pathogenic mechanisms to treatment.
Correale J, Gaitán MI, Ysrraelit MC, Fiol MP. Correale J, et al. Brain. 2017 Mar 1;140(3):527-546. doi: 10.1093/brain/aww258. Brain. 2017. PMID: 27794524 Review.
In contrast, current therapeutic options for progressive multiple sclerosis remain comparatively disappointing and challenging. ...Although most previous clinical trials in progressive multiple sclerosis have yielded disappointing results, important le …
In contrast, current therapeutic options for progressive multiple sclerosis remain comparatively disappointing and challenging …
Multiple sclerosis - a review.
Dobson R, Giovannoni G. Dobson R, et al. Eur J Neurol. 2019 Jan;26(1):27-40. doi: 10.1111/ene.13819. Epub 2018 Nov 18. Eur J Neurol. 2019. PMID: 30300457 Review.
Multiple sclerosis (MS) is the commonest non-traumatic disabling disease to affect young adults. The incidence of MS is increasing worldwide, together with the socioeconomic impact of the disease. ...
Multiple sclerosis (MS) is the commonest non-traumatic disabling disease to affect young adults. The incidence of MS is increa
Multiple sclerosis.
Nicholas R, Rashid W. Nicholas R, et al. Am Fam Physician. 2013 May 15;87(10):712-4. Am Fam Physician. 2013. PMID: 23939450 Free article. Review. No abstract available.
Classification, diagnosis, and differential diagnosis of multiple sclerosis.
Katz Sand I. Katz Sand I. Curr Opin Neurol. 2015 Jun;28(3):193-205. doi: 10.1097/WCO.0000000000000206. Curr Opin Neurol. 2015. PMID: 25887774 Review.
SUMMARY: Current multiple sclerosis phenotypic classifications include relapsing-remitting multiple sclerosis, clinically isolated syndrome, radiologically isolated syndrome, primary-progressive multiple sclerosis, and secondary-progressi …
SUMMARY: Current multiple sclerosis phenotypic classifications include relapsing-remitting multiple sclerosis, c …
Epidemiology of Multiple Sclerosis.
Howard J, Trevick S, Younger DS. Howard J, et al. Neurol Clin. 2016 Nov;34(4):919-939. doi: 10.1016/j.ncl.2016.06.016. Epub 2016 Aug 18. Neurol Clin. 2016. PMID: 27720001 Review.
The epidemiology of multiple sclerosis (MS) includes a consideration of genetic and environmental factors. Comparative studies of different populations have revealed prevalence and incidence rates that vary with geography and ethnicity. ...
The epidemiology of multiple sclerosis (MS) includes a consideration of genetic and environmental factors. Comparative studies …
Multiple Sclerosis.
Yamout BI, Alroughani R. Yamout BI, et al. Semin Neurol. 2018 Apr;38(2):212-225. doi: 10.1055/s-0038-1649502. Epub 2018 May 23. Semin Neurol. 2018. PMID: 29791948 Review.
Multiple sclerosis (MS) is a chronic central nervous system inflammatory disease of autoimmune etiology, mediated by activated T cells with evolving evidence of a significant contribution from B cells and cells of the innate immune system. ...
Multiple sclerosis (MS) is a chronic central nervous system inflammatory disease of autoimmune etiology, mediated by activated
Multiple sclerosis, a treatable disease.
Doshi A, Chataway J. Doshi A, et al. Clin Med (Lond). 2016 Dec;16(Suppl 6):s53-s59. doi: 10.7861/clinmedicine.16-6-s53. Clin Med (Lond). 2016. PMID: 27956442 Free PMC article. Review.
This article reviews our current understanding and modern treatment of multiple sclerosis (MS). MS is a disabling condition resulting in devastating social and economic impacts. ...
This article reviews our current understanding and modern treatment of multiple sclerosis (MS). MS is a disabling condition re …
Multiple sclerosis.
Owens B. Owens B. Nature. 2016 Nov 30;540(7631):S1. doi: 10.1038/540S1a. Nature. 2016. PMID: 27902684 No abstract available.
Multiple sclerosis.
[No authors listed] [No authors listed] Nat Rev Dis Primers. 2018 Nov 8;4(1):44. doi: 10.1038/s41572-018-0046-z. Nat Rev Dis Primers. 2018. PMID: 30410088 No abstract available.
91,028 results
Jump to page
Feedback